Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMN003: PCD vs PD in relapsed or refractory multiple myeloma
NCT03143049Phase 3Unknown
- Sponsor
- National University Hospital
- Start
- Sep 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide in multiple myeloma (MM), sponsored by National University Hospital. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03143049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03143049.